Literature DB >> 29087210

Reply to Morice et al.: Developing Clinical Guidelines.

Noah C Schoenberg1, Kevin C Wilson1.   

Abstract

Mesh：

Year:  2018        PMID： 29087210      PMCID： PMC5955055          DOI： 10.1164/rccm.201710-2039LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

1.  The predictive validity of quality of evidence grades for the stability of effect estimates was low: a meta-epidemiological study.

Authors:  Gerald Gartlehner; Andreea Dobrescu; Tammeka Swinson Evans; Carla Bann; Karen A Robinson; James Reston; Kylie Thaler; Andrea Skelly; Anna Glechner; Kimberly Peterson; Christina Kien; Kathleen N Lohr
Journal:  J Clin Epidemiol       Date:  2015-09-03       Impact factor: 6.437

2.  Developing Clinical Guidelines: 99% Faster Is Not Enough.

Authors:  Jerry A Krishnan
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

3.  A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development Methodologies.

Authors:  Noah C Schoenberg; Alan F Barker; John Bernardo; Robin R Deterding; Jerrold J Ellner; Dean R Hess; Neil R MacIntyre; Fernando J Martinez; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

4.  The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses.

Authors:  Reem A Mustafa; Nancy Santesso; Jan Brozek; Elie A Akl; Stephen D Walter; Geoff Norman; Mahan Kulasegaram; Robin Christensen; Gordon H Guyatt; Yngve Falck-Ytter; Stephanie Chang; Mohammad Hassan Murad; Gunn E Vist; Toby Lasserson; Gerald Gartlehner; Vijay Shukla; Xin Sun; Craig Whittington; Piet N Post; Eddy Lang; Kylie Thaler; Ilkka Kunnamo; Heidi Alenius; Joerg J Meerpohl; Ana C Alba; Immaculate F Nevis; Stephen Gentles; Marie-Chantal Ethier; Alonso Carrasco-Labra; Rasha Khatib; Gihad Nesrallah; Jamie Kroft; Amanda Selk; Romina Brignardello-Petersen; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2013-04-23       Impact factor: 6.437
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.